Plyzer Technologies Announces New SaaS Customer for its business intelligence software: Exeltis
Plyzer continues to build sales momentum for its business and analytics platform
Plyzer Technologies Inc. ("the Company") (PLYZ: OTCQB) is pleased to announce that it has signed Exeltis, company bellowing to Insud Pharma pharmaceutical group, as a new SaaS customer for its business intelligence and analytics software, Plyzer Intelligence.
Exeltis is a global healthcare organization which operates through a network of more than
40 subsidiaries, employing close to 4,000 professionals across over 40 countries. Exeltis is under the umbrella of Insud Pharma, an integrated health sciences group. For more information on Exeltis, please visit https://www.exeltis.com/
“We are very happy to partner with Exeltis because they have a strong position in the
women’s health sector and other areas such as respiratory, dermatology and ophthalmology.
We will help them make critical and strategic short-term decisions, while also fulfilling long-
term goals with respect to their use of data and business intelligence”, said Luis Pallares, founder and CEO of Plyzer Technologies Corporation.
Plyzer Technologies Inc. is a provider of custom, real-time, cloud-based business intelligence solutions for brands to analyze critical online price and market data in real time. Plyzer's highly customizable dashboard lets you adapt national, regional and local sales strategies, as well as production and logistics operations for companies of any size to adapt to prevailing market conditions at a competitive speed. The Company's technology is also being used to bring real-time price comparison reporting to the consumer market. These solutions are both driven by Plyzer's own artificial intelligence and machine learning technologies.
Plyzer Technologies has offices in Barcelona, Spain and Toronto, Canada.
Plyzer Technologies securities are traded through the facilities of the OTCQB market under the symbol PLYZ.